Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The apicoplast ribosome peptidyl transferase center (PTC) is the catalytic core of the protein synthesis machinery located within the apicoplast, a non-photosynthetic plastid essential for the survival of Apicomplexan parasites such as Plasmodium falciparum and Toxoplasma gondii (Source: PubMed, PMID: 17703225). This site is primarily composed of the 23S ribosomal RNA and is responsible for catalyzing peptide bond formation during the elongation phase of translation. Because the apicoplast is of endosymbiotic prokaryotic origin, its ribosome shares high structural homology with bacterial ribosomes but differs significantly from the eukaryotic 80S ribosomes of the human host (Source: UniProt). This structural divergence allows for selective targeting by various antibiotics, including macrolides, lincosamides, and chloramphenicol, which bind to the PTC and obstruct protein synthesis (Source: PMC, PMC3384643). A unique feature of targeting this site is the delayed death phenomenon, where the parasite's progeny fail to survive despite the initial generation appearing unaffected (Source: PubMed, PMID: 9192655). Consequently, the apicoplast PTC is a validated therapeutic target for treating malaria and toxoplasmosis, though its slow-acting nature often requires combination therapy with faster-acting agents.
Inhibition of protein translation by binding to the 50S ribosomal subunit and blocking the peptidyl transferase reaction, preventing peptide bond formation and nascent chain elongation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apicoplast ribosome peptidyl transferase center (Apicoplast PTC).